Please login to the form below

Not currently logged in
Email:
Password:

Sir John Bell

This page shows the latest Sir John Bell news and features for those working in and with pharma, biotech and healthcare.

Brexit rebels win vote on European Medicines Agency alignment

Brexit rebels win vote on European Medicines Agency alignment

Brexit rebels win vote on European Medicines Agency alignment. EMA membership will be a key negotiating aim; Sir John Bell sees independent MHRA post-Brexit. ... Sir John Bell, life sciences leader and author of the UK life sciences industrial strategy

Latest news

  • UK trumpets life sciences post-Brexit ‘sector deal’ UK trumpets life sciences post-Brexit ‘sector deal’

    The sector deal follows the UK’s industrial strategy white paper – drawn up by geneticist Sir John Bell – which pledged a series of new R&D investments. ... As laid out in Sir John’s paper, the sector deal focuses on key themes including

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    s position for the good of the country, and that's what Sir John Bell clearly indicates.". ... In which case I think there's a fantastic future. If we fail to respond to it we're going to have some hard times and the Sir John Bell report

  • UK life sciences sector sets out its post-Brexit growth proposals UK life sciences sector sets out its post-Brexit growth proposals

    UK life sciences sector sets out its post-Brexit growth proposals. Review helmed by Sir John Bell outlines a wide-ranging strategy. ... It’s helmed by geneticist Sir John Bell, who was tasked by the government to bring industry together to set out the

  • Novo Nordisk invests £115m in Oxford diabetes unit Novo Nordisk invests £115m in Oxford diabetes unit

    Sir John Bell, Oxford University's professor of medicine, said the collaboration will allow for daily interactions between academic and industrial scientists and "underlines the importance of sharing research and

  • Pharma must ‘create new social contract’ Pharma must ‘create new social contract’

    The letter comes from Professor Sir John Bell (pictured) and Professor Sir John Tooke, the co-chairs of CASMI - the Centre for the Advancement of Sustainable Medical Innovation - a partnership between ... Professor Sir John Bell, who has prompted the

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Pulling together Pulling together

    Responding to these at the end of August saw Sir John Bell publish his ambitious Life Sciences Industrial Strategy report, which offers a wide-ranging plan for making the UK a ... It’s a theme that appears in Sir John Bell’s report, where one of its

  • Pharma deals in March 2015 Pharma deals in March 2015

    Sir John Bell, Regius Professor of Medicine at Oxford University and a non-executive director of Immunocore has criticised the City of London for failing to provide financial support to life

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Life at the end of the Brexit tunnel

    Sir John Bell outlined the Life Sciences Industrial Strategy, which includes £160 million of funding to support the health sector, including the NHS. ... As an example of this, Sir John Bell suggested that Artificial Intelligence could be combined with

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics